A vehicle for photodynamic therapy of skin cancer: Influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy

Journal of Controlled Release

Volumn 65, Issue 3, 2000, Pages 359-366

  De Rosa, Fernanda Scarmato ^a   Marchetti, Juliana Maldonado ^a   Thomazini, José Antônio ^a   Tedesco, Antônio Cláudio ^b   Bentley, Maria Vitória Lopes Badra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Cie e Letras de Ribeirao Preto   (Brazil)

Author keywords

5 Aminolevulinic acid; Confocal scanning laser microscopy; Dimethylsulphoxide; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EMULSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER;

AMINOLEVULINIC ACID; ANIMALS; DIMETHYL SULFOXIDE; HUMANS; MICE; MICE, INBRED HRS; MICROSCOPY, CONFOCAL; MYRISTATES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; SOLUBILITY; VEHICLES;

EID: 0033995726     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00213-8     Document Type: Article

References (30)

1. Grossman D., Leffell D.J. The molecular basis of nonmelanoma skin cancer. Arch. Dermatol. 133:1997;1263-1270.
2. Peng Q., Moan J., Nesland J.M. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastructural Pathology. 20:1996;109-129.
3. Ortel B., Calzavara-Pinton P.G., Szeimies R.M., Hasan T. Perspectives in cutaneous photodynamic sensitization. J. Photochem. Photobiol. B: Biol. 36:1996;209-211.
4. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H.B., Nesland J.M., Giercksky K.E. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloucerative basal cell carcinoma. Photochem. Photobiol. 62:1995;906-913.
5. Roberts D.J., Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br. J. Plast. Surgery. 48:1995;369-370.
6. Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol. 6:1990;143-148.
7. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol B: Biol. 14:1992;275-292.
8. Peng Q., Berg K., Moan J., Kongshaug M., Nesland J.M. 5-Aminolevulinic acid acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65:1997;235-251.
9. Szeimies R.M., Calzavara-Pinton P.G., Karrer S., Ortel B., Landthaler M. Topical photodynamic therapy in dermatology. J. Photochem. Photobiol. B: Biol. 36:1996;213-219.
10. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.E., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer. 79:1997;2282-2308.
11. Fritsch C., Goerz G., Ruzicka T. Photodynamic therapy in dermatology. Arch. Dermatol. 134:1998;207-214.
12. Karrer S., Szeimeis R.M., Hohenleutner U., Heine A., Landthaler M. Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology. 190:1995;218-222.
13. Lui H., Salasche S., Kollias N., Flotte T., Mclean D., Anderson R.R. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid; a clinical and histological study. Arch. Dermatol. 131:1995;737-738.
14. Morton C.A., Whitehurst C., Moseley H., Mccoll J.H., Moore J.V., Mackie R. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatol. 135:1996;766-771.
15. Jeffes E.W., Mccullough J.L., Weinstein G.D., Fergin P.E., Nelson J.S., Shull T.F., Simpson K.R., Bukaty L.M., Hoffman W.L., Fong N.L. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch. Dermatol. 133:1997;727-732.
16. Malik Z., Kostenich G., Roitman L., Ehrenberg B., Orenstein A. Topical application of 5-aminolevulinic acid, DMSO, and EDTA: protoporphyrin IX accumulation in skin and tumors of mice. J. Photochem. Photobiol. B: Biol. 28:1995;213-218.
17. Barry B.W. Dermatological Formulation: Percutaneous Absorption, Drugs and Pharmaceutical Sciences. Vol. 18:1983;Marcel Dekker, New York.
18. H Conder L., Woodard S.I., Dailey H.A. Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation. Biochem. J. 275:1991;321-326.
19. Malik Z., Djaldetti M. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. Cell Different. 8:1979;223-233.
20. D Brooker J., Strivastava G., K May B., H Elliot W. Radiochemical assay for 5-aminolevulinic synthase. Enzyme. 28:1982;109-119.
21. Hanania J., Malik Z. The effect of EDTA and serum on endogenous-porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett. 65:1992;127-131.
22. Oishi H., Nomiyama H., Nomiyama K., Tomokuni K. Fluorimetric HPLC determination of Δ-aminolevulinic acid (5-ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J. Anal. Toxicol. 20:1996;106-110.
23. Bretschko E., Szeimies R.M., Landthaler M., Lee G. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro. J. Control Rel. 42:1996;203-208.
24. Iinuma S., Bachor R., Flotte T., Hasan T. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J. Urology. 153:1995;802-806.
25. Van Der Veen N., De Bruijn H.S., Star W.M. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Int. J. Cancer. 72:1997;110-118.
26. Novo M., Hüttmann G., Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol. B: Biol. 34:1996;143-148.
27. Liu P., Nightingale A.S., Kurihara-Bergstrom T. Variation of human skin permeation in vitro: ionic vs. neutral compounds. Int. J. Pharm. 90:1993;171-176.
28. Anigbogu A.N.C., Williams A.C., Barry B.W., Edwards H.G.M. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethylsulfoxide and human stratum corneum. Int. J. Pharm. 125:1995;265-282.
29. Berg K., Anholt H., Bech Ø., Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells. Br. J. Cancer. 74:1996;688-697.
30. Divaris D.X., Kennedy J.C., Pottier R.H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol. 136:1990;891-897.